Antegenes
- Website
- antegenes.com
- Last Round
- SeedAug 2022
- Rounds
- 1
About
Antegenes is a Biotech company. Its most recent funding was a Seed round in Aug 2022. Investors include EIT Health.
Funding History
SeedAug 2022
Aug 2022
Investors
Similar Companies

GRAILIPO
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Ultima Genomics
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/antegenes"><img src="https://indexed.vc/api/badge/company/antegenes" alt="Antegenes on Indexed.vc" width="260" height="76" /></a>
